This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Anaeropharma Science, Inc.. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Matsumoto, JP (2013)
- Nagano, JP (2013 - 2017)
Company Filing History:
Years Active: 2013-2017
Title: Yuko Shimatani-Shibata: Innovator in Gene Therapy
Introduction
Yuko Shimatani-Shibata is a prominent inventor based in Nagano, Japan. He has made significant contributions to the field of gene therapy, particularly in the treatment of ischemic diseases. With a total of 5 patents to his name, Shimatani-Shibata is recognized for his innovative approaches to medical challenges.
Latest Patents
One of his latest patents focuses on a therapeutic agent for ischemic diseases. The objective of this invention is to provide a gene transfer carrier that specifically accumulates at a disease site, even with systemic administration. This carrier boasts a high protein expression rate and is designed to disappear from the disease site as the condition improves. The solution involves a gene transfer carrier formed from an anaerobic bacterium that can grow specifically at the site of an ischemic disease. This bacterium can express at least one type of protein useful for the diagnosis or treatment of ischemic diseases. Additionally, he has developed a transfection vector that includes a novel secretory signal and a plasmid containing this signal, along with a transformed anaerobic bacterium and a pharmaceutical composition containing the gene transfer carrier.
Career Highlights
Yuko Shimatani-Shibata is currently associated with Anaeropharma Science, Inc., where he continues to advance his research and innovations. His work has garnered attention in the scientific community, contributing to the understanding and treatment of ischemic conditions.
Collaborations
Shimatani-Shibata collaborates with notable colleagues, including Takayuki Sasaki and Hitomi Shimizu-Matsuhashi, who contribute to his research endeavors.
Conclusion
Yuko Shimatani-Shibata is a key figure in the field of gene therapy, with a focus on innovative solutions for ischemic diseases. His contributions through patents and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile